Total Funding
$93.4M
Employee Range
11-50
AbolerIS Pharma offers a unique approach to treating inflammatory, autoimmune, and degenerative diseases by promoting immune tolerance while preserving beneficial immune responses. This innovative approach allows for the development of new drugs in critical areas of medical need.
AbolerIS Pharma data powered by:
Share
AbolerIS Pharma data powered by:
AbolerIS PharmaOverall Ranking
Regional Rank
Share
Loading...
In Western Europe
Top null%out of startups
AbolerIS PharmaIndustry Rankings in
Healthtech
City Rank
Share
1st
In Nantes
Top 17%out of 6 startups
National Rank
Share
79th
In France
Top 17%out of 473 startups
Regional Rank
Share
517th
In Western Europe
Top 12%out of 4548 startups
AbolerIS PharmaSubindustry Rankings in
BiotechnologyCity Rank
Share
1st
In Nantes
Top 20%out of 5 startups
National Rank
Share
21st
In France
Top 10%out of 214 startups
Regional Rank
Share
181st
In Western Europe
Top 11%out of 1726 startups
rankings by:
AbolerIS PharmaSB Rank Evolution
Not enough data points to display the chart.
AbolerIS PharmastartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro